Research Article

SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma

Figure 5

Promoter methylation levels of SLC2A5 in LUAD. Promoter methylation levels of SLC2A5 were low in (a)–(f). LUAD: (a) sample type, (b) gender, (c) race, (d) TP53 mutation status, (e) individual cancer stages, and (f) age (, , and ).
(a)
(b)
(c)
(d)
(e)
(f)